Download PDF Download PDF

Life Science Alliance

Publication date: 2020-09-01
Publisher: Life Science Alliance LLC

Author:

Kim, Hyoung Kyu
Ko, Tae Hee ; Song, In-Sung ; Jeong, Yu Jeong ; Heo, Hye Jin ; Jeong, Seung Hun ; Kim, Min ; Park, Nam Mi ; Seo, Dae Yun ; Pham, Trong Kha ; Kim, Sun-Woo ; Lee, Sung Ryul ; Cho, Sung Woo ; Won, Jong Chul ; Youm, Jae Boum ; Ko, Kyung Soo ; Rhee, Byoung Doo ; Kim, Nari ; Cho, Kyoung Im ; Shimizu, Ippei ; Minamino, Tohru ; Ha, Nam-Chul ; Park, Young Shik ; Nilius, Bernd ; Han, Jin

Keywords:

Science & Technology, Life Sciences & Biomedicine, Biology, Life Sciences & Biomedicine - Other Topics, RAT MODEL, TETRAHYDROBIOPTERIN, PROTECTS, FIBROSIS, HEART, AMP-Activated Protein Kinases, Animals, Biopterins, Calcium-Calmodulin-Dependent Protein Kinase Kinase, Cyclic AMP Response Element-Binding Protein, Diabetes Mellitus, Diabetic Cardiomyopathies, Heart, Male, Mice, Mice, Inbred C57BL, Mitochondria, Myocardial Contraction, Myocardium, Myocytes, Cardiac, Organelle Biogenesis, Oxidative Phosphorylation, Rats, Rats, Long-Evans, Signal Transduction, 31 Biological sciences, 32 Biomedical and clinical sciences

Abstract:

Diabetic cardiomyopathy (DCM) is a major cause of mortality/morbidity in diabetes mellitus patients. Although tetrahydrobiopterin (BH4) shows therapeutic potential as an endogenous cardiovascular target, its effect on myocardial cells and mitochondria in DCM and the underlying mechanisms remain unknown. Here, we determined the involvement of BH4 deficiency in DCM and the therapeutic potential of BH4 supplementation in a rodent DCM model. We observed a decreased BH4:total biopterin ratio in heart and mitochondria accompanied by cardiac remodeling, lower cardiac contractility, and mitochondrial dysfunction. Prolonged BH4 supplementation improved cardiac function, corrected morphological abnormalities in cardiac muscle, and increased mitochondrial activity. Proteomics analysis revealed oxidative phosphorylation (OXPHOS) as the BH4-targeted biological pathway in diabetic hearts as well as BH4-mediated rescue of down-regulated peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC-1α) signaling as a key modulator of OXPHOS and mitochondrial biogenesis. Mechanistically, BH4 bound to calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and activated downstream AMP-activated protein kinase/cAMP response element binding protein/PGC-1α signaling to rescue mitochondrial and cardiac dysfunction in DCM. These results suggest BH4 as a novel endogenous activator of CaMKK2.